Medicxi Ventures Management (Jersey) Ltd - Jan 24, 2024 Form 3 Insider Report for Phathom Pharmaceuticals, Inc. (PHAT)

Role
10%+ Owner
Signature
MEDICXI VENTURES MANAGEMENT (JERSEY) LIMITED, By: /s/ Giles Johnstone-Scott, Director
Stock symbol
PHAT
Transactions as of
Jan 24, 2024
Transactions value $
$0
Form type
3
Date filed
1/26/2024, 04:35 PM
Previous filing
Mar 23, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding PHAT Common Stock 3.67M Jan 24, 2024 By Medicxi Growth I LP F1
holding PHAT Common Stock 87.3K Jan 24, 2024 By Medicxi Growth Co-Invest I LP F2
holding PHAT Common Stock 3.64M Jan 24, 2024 By Medicxi IV LP F3
holding PHAT Common Stock 62K Jan 24, 2024 By Medicxi Co-Invest IV LP F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares held by Medicxi Growth I LP ("Growth I"). Medicxi Growth I GP Limited ("Growth I GP") is the sole general partner of Growth I, and Medicxi Ventures Management (Jersey) Limited ("Medicxi Manager") is the sole manager of Growth I. The Reporting Persons disclaim Section 16 beneficial ownership of the securities held by Growth I, except to the extent of their respective pecuniary interest therein, if any, and this report shall not be deemed to be an admission that they are the beneficial owners of such shares for Section 16 or any other purpose.
F2 Shares held by Medicxi Growth Co-Invest I LP ("Growth Co-Invest I"). Growth I GP is the sole general partner of Growth Co-Invest I, and Medicxi Manager is the sole manager of Growth Co-Invest I. The Reporting Persons disclaim Section 16 beneficial ownership of the securities held by Growth Co-Invest I, except to the extent of their respective pecuniary interest therein, if any, and this report shall not be deemed to be an admission that they are the beneficial owners of such shares for Section 16 or any other purpose.
F3 Shares held Medicxi IV LP ("Medicxi IV"). Medicxi IV GP Limited ("Medicxi IV GP") is the sole general partner of Medicxi IV, and Medicxi Manager is the sole manager of Medicxi IV. The Reporting Persons disclaim Section 16 beneficial ownership of the securities held by Medicxi IV, except to the extent of their respective pecuniary interest therein, if any, and this report shall not be deemed to be an admission that they are the beneficial owners of such shares for Section 16 or any other purpose.
F4 Shares held by Medicxi Co-Invest IV LP ("Co-Invest IV"). Medicxi IV GP is the sole general partner of Co-Invest IV, and Medicxi Manager is the sole manager of Co-Invest IV. The Reporting Persons disclaim Section 16 beneficial ownership of the securities held by Co-Invest IV, except to the extent of their respective pecuniary interest therein, if any, and this report shall not be deemed to be an admission that they are the beneficial owners of such shares for Section 16 or any other purpose.